Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque

AIDS Research and Human Retroviruses
Mauricio A MartinsDavid I Watkins

Abstract

Effector memory T cell (TEM) responses display potent antiviral properties and have been linked to stringent control of simian immunodeficiency virus (SIV) replication. Since recurrent antigen stimulation drives the differentiation of CD8+ T cells toward the TEM phenotype, in this study we incorporated a persistent herpesviral vector into a heterologous prime/boost/boost vaccine approach to maximize the induction of TEM responses. This new regimen resulted in CD8+ TEM-biased responses in four rhesus macaques, three of which controlled viral replication to <1,000 viral RNA copies/ml of plasma for more than 6 months after infection with SIVmac239. Over the course of this study, we made a series of interesting observations in one of these successful controller animals. Indeed, in vivo elimination of CD8αβ+ T cells using a new CD8β-depleting antibody did not abrogate virologic control in this monkey. Only after its CD8α+ lymphocytes were depleted did SIV rebound, suggesting that CD8αα+ but not CD8αβ+ cells were controlling viral replication. By 2 weeks postinfection (PI), the only SIV sequences that could be detected in this animal harbored a small in-frame deletion in nef affecting six amino acids. Deep sequencing of the SIVmac239...Continue Reading

References

Jan 26, 1995·The New England Journal of Medicine·F KirchhoffR C Desrosiers
Aug 26, 1998·The Journal of General Virology·M P CranageG A Hall
Apr 21, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·B Damania, R C Desrosiers
Oct 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zdenek HelGenoveffa Franchini
Mar 23, 2004·Annual Review of Immunology·Hilde Cheroutre
Apr 24, 2004·Science·Loui T MadakamutilHilde Cheroutre
May 12, 2005·Immunology·Ramothea L Webster, R Paul Johnson
Dec 21, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zdenek HelGenoveffa Franchini
Jul 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·David MasopustRafi Ahmed
Jan 26, 2007·Journal of Virology·Thomas C FriedrichDavid I Watkins
Jun 1, 2007·Journal of Virology·John T LoffredoDavid I Watkins
Jun 12, 2010·Biologicals : Journal of the International Association of Biological Standardization·J L ExclerW C Koff

❮ Previous
Next ❯

Datasets Mentioned

BETA
SRP016012

Methods Mentioned

BETA
blood drawn
enzyme-linked
ELISA
PCR
454 sequencing
chips
biopsies
454 deep sequencing

Software Mentioned

Mosaik
FAT
Phaser
VICUNA
FlowJo

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.